Gary R Matzke
机构: Professor, Virginia Commonwealth University
每年引用次数
引用次数
引用: 11,712
H-指数: 47
I10-指数 : 128
出版物: 324
Hemodialysis clearance of total and unbound lidocaine.
G R Matzke , H McCoy , J Jacobi , R W McGory
Clinical pharmacy 2 ( 1) 54 -57
3
1983
Treating severe metabolic alkalosis.
W J Martin , G R Matzke
Clinical pharmacy 1 ( 1) 42 -48
20
1982
Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
R B Blevins , N G Salem , C E Halstenson , G R Matzke
Clinical Nephrology 22 ( 5) 239 -243
19
1984
Variability in pharmacokinetic values for gentamicin, tobramycin, and netilmicin in patients with renal insufficiency.
G R Matzke , J M Kovarik , S P Millikin
Clinical pharmacy 8 ( 11) 800 -806
5
1989
Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
R H Barbhaiya , C A Knupp , S T Forgue , K A Pittman
Drug Metabolism and Disposition 19 ( 1) 68 -73
38
1991
Development of competency standards for quality assurance in clinical pharmacokinetics
R L Lucarotti , G R Matzke , W S Burkle
Hospital Pharmacy 15 ( 10) 494 -496
4
1980
The influence of type i and type ii diabetes mellitus on antipyrine disposition
G R Matzke , S W Carson , R F Frye , J A Lyon
Clinical Pharmacology & Therapeutics 51 ( 2) 134
2
1992
Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysis.
K L Heim , C E Halstenson , C M Comty , M B Affrime
Antimicrobial Agents and Chemotherapy 30 ( 1) 15 -19
9
1986
Cefsulodin pharmacokinetics in patients with various degrees of renal function.
G R Matzke , W F Keane
Antimicrobial Agents and Chemotherapy 23 ( 3) 369 -373
6
1983
Hemodialysis elimination rates and clearance of gentamicin and tobramycin.
G R Matzke , C E Halstenson , W F Keane
Antimicrobial Agents and Chemotherapy 25 ( 1) 128 -130
25
1984
Pharmacokinetics of vancomycin in patients with various degrees of renal function
G R Matzke , R W McGory , C E Halstenson , W F Keane
Antimicrobial Agents and Chemotherapy 25 ( 4) 433 -437
429
1984
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
R D Blevins , C E Halstenson , N G Salem , G R Matzke
Antimicrobial Agents and Chemotherapy 25 ( 5) 603 -606
35
1984
Disposition of roxithromycin in patients with normal and severely impaired renal function.
C E Halstenson , J A Opsahl , M H Schwenk , J M Kovarik
Antimicrobial Agents and Chemotherapy 34 ( 3) 385 -389
14
1990
Disposition of cefmetazole in healthy volunteers and patients with impaired renal function.
C E Halstenson , D R Guay , J A Opsahl , C A Hirata
Antimicrobial Agents and Chemotherapy 34 ( 4) 519 -523
9
1990
Apparent biliary pseudolithiasis during ceftriaxone therapy.
K L Heim-Duthoy , E M Caperton , R Pollock , G R Matzke
Antimicrobial Agents and Chemotherapy 34 ( 6) 1146 -1149
78
1990
Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency.
J S Kelloway , W M Awni , C C Lin , J Lim
Antimicrobial Agents and Chemotherapy 35 ( 11) 2267 -2274
18
1991
Disposition of ceftazidime in surgical patients with intra-abdominal infection
K L Heim-Duthoy , M P Bubrick , D M Cocchetto , G R Matzke
Antimicrobial Agents and Chemotherapy 32 ( 12) 1845 -1847
6
1988
Pharmacokinetics of cefonicid in patients with skin and skin structure infections.
K L Heim-Duthoy , G L Peltier , D R Guay , G R Matzke
Antimicrobial Agents and Chemotherapy 32 ( 4) 485 -487
2
1988
Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.
D R Guay , W M Awni , C E Halstenson , M T Kenny
Antimicrobial Agents and Chemotherapy 33 ( 11) 2012 -2015
12
1989
Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease.
C E Halstenson , C A Hirata , K L Heim-Duthoy , P A Abraham
Antimicrobial Agents and Chemotherapy 34 ( 1) 128 -133
21
1990